BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1244 related articles for article (PubMed ID: 9068464)

  • 1. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.
    Sung JJ; Leung VK; Chung SC; Ling TK; Suen R; Cheng AF; Li AK
    Am J Gastroenterol; 1995 Sep; 90(9):1424-7. PubMed ID: 7661162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
    Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
    Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
    Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.
    Calvet X; García N; Campo R; Brullet E; Comet R; Navarro M
    Am J Gastroenterol; 1998 Jun; 93(6):932-4. PubMed ID: 9647022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection.
    Hsieh YH; Lin HJ; Tseng GY; Perng CL; Chang FY; Lee SD
    Hepatogastroenterology; 2001; 48(40):1078-81. PubMed ID: 11490804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
    Zala G; Schwery S; Giezendanner S; Flury R; Wüst J; Meyenberger C; Wirth HP
    Schweiz Med Wochenschr; 1996 Feb; 126(5):153-8. PubMed ID: 8685685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
    Thijs JC; van Zwet AA; Moolenaar W; Wolfhagen MJ; ten Bokkel Huinink J
    Am J Gastroenterol; 1996 Jan; 91(1):93-7. PubMed ID: 8561152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
    Graham DY; Belson G; Abudayyeh S; Osato MS; Dore MP; El-Zimaity HM
    Dig Liver Dis; 2004 Jun; 36(6):384-7. PubMed ID: 15248377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
    Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
    Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin.
    Bertoni G; Sassatelli R; Nigrisoli E; Tansini P; Bianchi G; Della Casa G; Bagni A; Bedogni G
    Am J Gastroenterol; 1996 Feb; 91(2):258-63. PubMed ID: 8607489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.